Clairity CEO, Jeff Luber, Presenting at BIO International Convention 2025
BOSTON--(BUSINESS WIRE)--Clairity, Inc., advancing AI-powered human health solutions, today announced that members of its executive …
Clairity Becomes the First FDA-Authorized AI Platform for Breast Cancer Prediction – Historic Milestone for Women’s Health
Clairity, Inc., a digital health innovator advancing AI-driven healthcare solutions, has received U.S. Food and Drug Administration …
The Breast Cancer Research Foundation Backs Clairity’s AI-Based Risk Assessment
Clairity, Inc. is proud to announce a $1M investment from the Breast Cancer Research Foundation (BCRF) in support of Clairity, a leading …
Clairity Appoints Jeffrey R. Luber CEO as Firm Prepares for Global Expansion
Clairity, Inc., a pioneer in AI-based predictive tools for breast cancer, is pleased to announce the appointment of Jeffrey R. Luber, …
